Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Keratin 19 (KRT19) (Middle Region) Peptide

KRT19 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN2183650
  • Target See all Cytokeratin 19 (KRT19) products
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Protein Region
    Middle Region
    Origin
    Human
    Source
    • 10
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    DMRSQYEVMA EQNRKDAEAW FTSRTEELNR EVAGHTEQLQ MSRSEVTDLR
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-KRT19 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeat freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Background
    KRT19 involved in the organization of myofibers. Together with KRT8, KRT19 helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.

    Alias Symbols: CK19, K19, K1CS

    Protein Size: 400
    Molecular Weight
    44 kDa
    Gene ID
    3880
    NCBI Accession
    NM_002276, NP_002267
    UniProt
    P08727
You are here:
Support